Mirion Technologies, Inc. Class A Common Stock (MIR)
15.87
0.00 (0.00%)
Mirion Technologies Inc. is a leading provider of advanced radiation detection and measurement solutions, serving a diverse range of industries such as healthcare, nuclear power, and defense
The company specializes in developing high-precision instruments and systems that are designed to detect, measure, and analyze radiation, enhancing safety and compliance for users around the globe. By leveraging cutting-edge technology and expertise, Mirion offers a comprehensive portfolio of products for both industrial and medical applications, including dosimetry, imaging, and monitoring systems. Their commitment to innovation and quality ensures that customers can effectively manage radiation exposure and maintain a safe working environment.
Mirion (NYSEMIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Teledyne (NYSETDY) and the best and worst performers in the inspection instruments industry.
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the inspection instruments industry, including Itron (NASDAQITRI) and its peers.
Let’s dig into the relative performance of Keysight (NYSEKEYS) and its peers as we unravel the now-completed Q3 inspection instruments earnings season.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Mirion (NYSEMIR) and the rest of the inspection instruments stocks fared in Q3.
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Badger Meter (NYSEBMI) and its peers.
Mirion (“we” or the “company”) (NYSEMIR), a leading provider of radiation safety solutions supporting advancements in nuclear power and cancer care, will host an Investor Day today, December 3, 2024, at 2:00pm ET. The event will be held at the New York Stock Exchange in New York, NY. In-person attendance requires prior registration. Interested parties may access the livestream of the event, related published materials and a replay of the event by accessing Mirion’s IR website at ir.mirion.com.
Mirion (NYSEMIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Goldman Sachs’ Industrials and Materials Conference in New York, NY. The presentation will begin at 10:40 AM ET on Thursday, December 5, 2024.
Radiation technology company Mirion (NYSEMIR) reported Q3 CY2024 results topping the market’s revenue expectations, with sales up 8.2% year on year to $206.8 million. Its GAAP loss of $0.07 per share was 40% below analysts’ consensus estimates.
Mirion (“we” or the “company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the third quarter ended September 30, 2024.
Mirion Technologies (NYSEMIR), a leading provider of advanced radiation safety solutions, today announced that it has been awarded two significant contracts to support the Sizewell C project, a new 3.2-gigawatt power station for Britain. Leveraging EDF expertise and EPR (European Pressurised Reactor) technology, Sizewell C will generate low-carbon electricity sufficient to power approximately 6 million homes. The development, based in East Suffolk, will mirror the design of the Hinkley Point C nuclear power station currently under construction in the Somerset region.
Mirion (NYSEMIR), a leading provider of radiation safety solutions supporting advancements in nuclear power and cancer care, today announced that it will host an Investor Day on Tuesday, December 3, 2024, beginning at 2:00 p.m. ET. The event will be held at the New York Stock Exchange and webcast live.
Mirion (NYSEMIR) announced today that it will release financial results for third quarter 2024 after market close on Tuesday, October 29, 2024. Following the news release, the company will host a conference call the next day, Wednesday, October 30, 2024, at 11:00 am ET to discuss the results.
Varian, a Siemens Healthineers company, and Sun Nuclear, a Mirion Medical company (NYSEMIR), announced an alliance to expand Varian’s comprehensive quality assurance (QA) offerings and interoperability for current and future radiotherapy solutions.
Mirion (“we” or the “company”) (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the second quarter ended June 30, 2024.
Mirion (NYSEMIR) announced today that it will release financial results for second quarter 2024 after market close on Thursday, August 1, 2024. Following the news release, the company will host a conference call the next day, Friday, August 2, 2024, at 11:00 am ET to discuss the results.
Mirion (NYSEMIR) announced today that its management team’s presentation at Jefferies’ 2024 Global Healthcare Conference will now begin at 3:30 PM ET on Thursday, June 6, 2024.
Mirion ("we" or the "Company") (NYSEMIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it completed the redemption of its outstanding publicly traded warrants (the “Public Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Shares”), that remained outstanding at 5:00 pm New York City time on Monday, May 20, 2024 (the “Redemption Date”), for a redemption price of $0.10 per Public Warrant (the “Redemption Price”).
